« Previous
Next »
Atherosclerosis
Volume 210, Issue 1
, Pages 43-44
, May 2010
MMP-2 genetic variant and plaque features of instability
References
- . Identification of a plasma gelatinase in preparations of fibronectin. J Biol Chem. 1986;261:4363–4366
- A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet. 2006;69:271–276
- Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26:1120–1125
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493–2503
- MMP2 genetic variation is associated with measures of fibrous cap thickness: the atherosclerosis risk in communities carotid MRI study. Atherosclerosis. 2010;
- . Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res. 2006;69:666–676
- . Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 2007;211:19–26
- . The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem. 1999;274:29130–29137
- Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004;64:7622–7628
- . Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001;276:7549–7558
- Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res. 2008;86:653–660
- . Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells. Reprod Biol Endocrinol. 2009;7:41
- Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol. 2006;207:729–734
- . Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem. 2002;277:32775–32780
- . p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. J Cell Physiol. 2006;208:246–252
- Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis. 2007;193:36–43
- . p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta. 2009;30:1029–1036
- MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:1330–1336
PII: S0021-9150(10)00160-7
doi: 10.1016/j.atherosclerosis.2010.02.019
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Atherosclerosis
Volume 210, Issue 1
, Pages 43-44
, May 2010
